Immune globulin intravenous and subcutaneous Interactions
There are 105 drugs known to interact with immune globulin intravenous and subcutaneous, along with 2 disease interactions. Of the total drug interactions, 85 are major, 19 are moderate, and 1 is minor.
- View all 105 medications that may interact with immune globulin intravenous and subcutaneous
- View immune globulin intravenous and subcutaneous disease interactions (2)
Most frequently checked interactions
View interaction reports for immune globulin intravenous and subcutaneous and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Ativan (lorazepam)
- B 100 Complex (multivitamin)
- Benadryl (diphenhydramine)
- Bentyl (dicyclomine)
- Bumex (bumetanide)
- Calcionate (calcium glubionate)
- Caltrate 600+D (calcium / vitamin d)
- Carafate (sucralfate)
- Cardizem (diltiazem)
- Cardura (doxazosin)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- Cequa (cyclosporine ophthalmic)
- Cipro (ciprofloxacin)
- Creon (pancrelipase)
- Crestor (rosuvastatin)
- D3 (cholecalciferol)
- Dexilant (dexlansoprazole)
- Dried Factor VIII Fraction Type 8Y (antihemophilic factor/von willebrand factor)
- Dulera (formoterol / mometasone)
- Ecotrin Maximum Strength (aspirin)
- Estro-Span 40 (estradiol)
- Fioricet (acetaminophen / butalbital / caffeine)
- Flebogamma (immune globulin intravenous)
- Lyrica (pregabalin)
- Plaquenil (hydroxychloroquine)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
Immune globulin intravenous and subcutaneous disease interactions
There are 2 disease interactions with immune globulin intravenous and subcutaneous which include:
Report options
QR code containing a link to this page
More about immune globulin intravenous and subcutaneous
- immune globulin intravenous and subcutaneous consumer information
- Compare alternatives
- Reviews (24)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.